BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10484944)

  • 1. Prediction of neuropsychological performance by neurological signs in schizophrenia.
    Arango C; Bartko JJ; Gold JM; Buchanan RW
    Am J Psychiatry; 1999 Sep; 156(9):1349-57. PubMed ID: 10484944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological signs and the heterogeneity of schizophrenia.
    Arango C; Kirkpatrick B; Buchanan RW
    Am J Psychiatry; 2000 Apr; 157(4):560-5. PubMed ID: 10739414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirmatory factor analysis of the Neurological Evaluation Scale in unmedicated schizophrenia.
    Sanders RD; Allen DN; D Forman S; Tarpey T; Keshavan MS; Goldstein G
    Psychiatry Res; 2005 Jan; 133(1):65-71. PubMed ID: 15698678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minor neurological and physical anomalies in patients with first-episode psychosis].
    Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
    Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
    Hobart MP; Goldberg R; Bartko JJ; Gold JM
    Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soft signs and neuropsychological performance in schizophrenia.
    Flashman LA; Flaum M; Gupta S; Andreasen NC
    Am J Psychiatry; 1996 Apr; 153(4):526-32. PubMed ID: 8599401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological abnormalities in schizophrenic patients and their siblings.
    Ismail B; Cantor-Graae E; McNeil TF
    Am J Psychiatry; 1998 Jan; 155(1):84-9. PubMed ID: 9433343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors, pre-morbid functioning and episode correlates of neurological soft signs in drug-naive patients with schizophrenia-spectrum disorders.
    Peralta V; de Jalón EG; Campos MS; Basterra V; Sanchez-Torres A; Cuesta MJ
    Psychol Med; 2011 Jun; 41(6):1279-89. PubMed ID: 20860873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of soft neurological signs in positive and negative subtype of schizophrenia.
    Cvetić T; Vuković O; Britvić D; Ivković M; Dukić-Dejanović S; Lecić-Tosevski D
    Psychiatr Danub; 2009 Jun; 21(2):174-8. PubMed ID: 19556945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses.
    Keshavan MS; Sanders RD; Sweeney JA; Diwadkar VA; Goldstein G; Pettegrew JW; Schooler NR
    Am J Psychiatry; 2003 Jul; 160(7):1298-304. PubMed ID: 12832245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia.
    Mohr F; Hubmann W; Albus M; Franz U; Hecht S; Scherer J; Binder J; Sobizack N
    Psychiatry Res; 2003 Nov; 121(1):21-30. PubMed ID: 14572621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between eye tracking disorder in schizophrenia and poor sensory integration.
    Ross DE; Buchanan RW; Medoff D; Lahti AC; Thaker GK
    Am J Psychiatry; 1998 Oct; 155(10):1352-7. PubMed ID: 9766766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness.
    Schatzberg AF; Posener JA; DeBattista C; Kalehzan BM; Rothschild AJ; Shear PK
    Am J Psychiatry; 2000 Jul; 157(7):1095-100. PubMed ID: 10873917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 12-Month stability of neurological soft signs in stabilized patients with schizophrenia.
    Fountoulakis KN; Panagiotidis P; Kimiskidis V; Nimatoudis I
    Nord J Psychiatry; 2019 Oct; 73(7):451-461. PubMed ID: 31393751
    [No Abstract]   [Full Text] [Related]  

  • 17. Neurological soft signs in first-episode schizophrenia: a follow-up study.
    Bachmann S; Bottmer C; Schröder J
    Am J Psychiatry; 2005 Dec; 162(12):2337-43. PubMed ID: 16330599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test-retest stability of the Repeatable Battery for the Assessment of Neuropsychological Status in schizophrenia.
    Wilk CM; Gold JM; Bartko JJ; Dickerson F; Fenton WS; Knable M; Randolph C; Buchanan RW
    Am J Psychiatry; 2002 May; 159(5):838-44. PubMed ID: 11986139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological soft signs discriminate schizophrenia from major depression but not bipolar disorder.
    Zhao Q; Ma YT; Lui SS; Liu WH; Xu T; Yu X; Tan SP; Wang ZR; Qu M; Wang Y; Huang J; Cheung EF; Dazzan P; Chan RC
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():72-8. PubMed ID: 23266480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological functions predict 1- and 3-year outcome in first-episode psychosis.
    Carlsson R; Nyman H; Ganse G; Cullberg J
    Acta Psychiatr Scand; 2006 Feb; 113(2):102-11. PubMed ID: 16423161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.